DK0426521T3 - Anvendelse af interleukin 2 til behandling af leukæmi - Google Patents

Anvendelse af interleukin 2 til behandling af leukæmi

Info

Publication number
DK0426521T3
DK0426521T3 DK90402900.6T DK90402900T DK0426521T3 DK 0426521 T3 DK0426521 T3 DK 0426521T3 DK 90402900 T DK90402900 T DK 90402900T DK 0426521 T3 DK0426521 T3 DK 0426521T3
Authority
DK
Denmark
Prior art keywords
leukaemias
human
treatment
interleukin
polypeptide
Prior art date
Application number
DK90402900.6T
Other languages
English (en)
Inventor
Maud Brandely
Dominique Maraninchi
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK0426521T3 publication Critical patent/DK0426521T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90402900.6T 1989-10-17 1990-10-16 Anvendelse af interleukin 2 til behandling af leukæmi DK0426521T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913546A FR2653020B1 (fr) 1989-10-17 1989-10-17 Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies.

Publications (1)

Publication Number Publication Date
DK0426521T3 true DK0426521T3 (da) 1994-05-02

Family

ID=9386473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90402900.6T DK0426521T3 (da) 1989-10-17 1990-10-16 Anvendelse af interleukin 2 til behandling af leukæmi

Country Status (13)

Country Link
US (1) US5582822A (da)
EP (1) EP0426521B1 (da)
JP (1) JP2961189B2 (da)
KR (1) KR0168420B1 (da)
AT (1) ATE103494T1 (da)
AU (1) AU640173B2 (da)
CA (1) CA2027725A1 (da)
DE (1) DE69007744T2 (da)
DK (1) DK0426521T3 (da)
FR (1) FR2653020B1 (da)
HU (1) HU206048B (da)
OA (1) OA09317A (da)
ZA (1) ZA907648B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671728B1 (fr) * 1991-01-17 1995-01-20 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des pneumathorax.
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5696079A (en) * 1993-05-19 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
US5419900A (en) 1993-05-19 1995-05-30 The United States Of America As Represented By The Department Of Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
CA2405709A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
US6852344B2 (en) * 2000-12-04 2005-02-08 Council Of Scientific And Industrial Research Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof
GB2372598A (en) * 2001-02-26 2002-08-28 Coppereye Ltd Organising data in a database
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
US6967034B2 (en) * 2002-05-31 2005-11-22 Council Of Scientific And Industrial Research Herbal-based composition for treating acute and chronic myeloid leukemia
CN100515416C (zh) * 2002-05-31 2009-07-22 科学及工业研究委员会 能作为抗白血病药物的草药分子
US20070161704A1 (en) * 2002-07-08 2007-07-12 Council Of Scientific And Industrial Research Pharmaceutical composition useful for treating chronic myeloid leukemia
US20040006138A1 (en) * 2002-07-08 2004-01-08 Council Of Scientific Pharmaceutical composition useful for treating chronic myeloid leukemia
US20050282892A1 (en) * 2002-07-08 2005-12-22 Santu Bandyopadhyay Pharmaceutical composition useful for treating chronic myeloid leukemia
WO2004024171A1 (en) * 2002-09-16 2004-03-25 Vasogen Ireland Limited Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine)
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
US7357652B1 (en) * 2006-10-27 2008-04-15 Leviton Manufacturing Company, Inc. Modular wiring system with locking elements
US8206920B2 (en) * 2007-03-26 2012-06-26 Arnold Ganser Diagnostic assay for the specific treatment of acute myeloid leukemia
US10622768B1 (en) 2019-05-10 2020-04-14 Walter Morgan Cowham Methods and systems for a modular plug-in bus wiring system
US10971879B1 (en) 2020-08-12 2021-04-06 Cowham Innovations, LLC. Electrical connection forming tool
CN111821423B (zh) * 2020-08-17 2023-04-11 中南大学湘雅二医院 一种白介素2用于治疗慢性自发性荨麻疹的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
ZA888978B (en) * 1987-12-04 1990-07-25 Du Pont Immobilized interleukin 2 and interleukin 2 containing a carboxylterminal extension
ZA898139B (en) * 1988-11-17 1990-08-29 Hoffmann La Roche Recombinant interleukin-2 hybrid proteins

Also Published As

Publication number Publication date
FR2653020B1 (fr) 1993-03-26
HU906463D0 (en) 1991-04-29
US5582822A (en) 1996-12-10
DE69007744T2 (de) 1994-07-28
HUT55241A (en) 1991-05-28
EP0426521B1 (fr) 1994-03-30
ATE103494T1 (de) 1994-04-15
ZA907648B (en) 1991-11-27
KR0168420B1 (ko) 1999-01-15
AU6466790A (en) 1991-04-26
CA2027725A1 (fr) 1991-04-18
FR2653020A1 (fr) 1991-04-19
EP0426521A1 (fr) 1991-05-08
HU206048B (en) 1992-08-28
OA09317A (fr) 1992-09-15
JP2961189B2 (ja) 1999-10-12
AU640173B2 (en) 1993-08-19
DE69007744D1 (de) 1994-05-05
KR910007541A (ko) 1991-05-30
JPH03193736A (ja) 1991-08-23

Similar Documents

Publication Publication Date Title
DK0426521T3 (da) Anvendelse af interleukin 2 til behandling af leukæmi
DE69034244D1 (de) Zytotoxischer Lymphozyten-Reifefaktor 35kD Untereinheit und monoklonale Antikörper spezifisch dafür
IL79085A0 (en) Hybrid interferons,their preparation and pharmaceutical compositions containing them
HK65693A (en) Pharmaceutical composition containing a human granulocyte colony stimulating factor for the treatment of leukopenia
ATE167519T1 (de) T-zellen-wachstumsfaktor
PT100651A (pt) Muteinas da interleucina 6 (il-6) isentas de cisteina
DK0452598T3 (da) Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer
ATE157544T1 (de) Verwendung von human-beta-interferon zur stimulierung der erythropoiesis
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
IE871358L (en) Interferon for carcinoma
DE3869789D1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DK0507825T3 (da) Antitumoralt præparat på basis af polypeptider med humant interleukin-2-aktivitet
ZA919682B (en) Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax
BG60657B2 (en) Human recombinant interleukin-2 muteins